<DOC>
	<DOCNO>NCT01200654</DOCNO>
	<brief_summary>Linezolid first new class antibacterial drug , oxazolidinones . It specific inhibitory activity Gram positive bacteria , include methicillin-resistant Staphylococcus aureus ( MRSA ) . Dosage 600 mg discontinuous administration twice day study safety volunteer . The intensive care unit patient , mechanical ventilation , severe sepsis , represent highly heterogeneous population responsible hight variability pharmacokinetics parameter ( augmentation total volume distribution , modification glomerular filtration ) wich lead antibiotic inefficacy . In first time , study describe pharmacokinetics Linezolid intensive care unit patient severe MRSA infection . The aim study define validate population pharmacokinetic model include influence patient ' characteristic pharmacokinetics Linezolid .</brief_summary>
	<brief_title>Population Pharmacokinetics Linezolid</brief_title>
	<detailed_description>The demographic , clinical biological parameter collect . Patients receive Linezolid 600 mg twice day administration 60 minute . Blood sample collected second day begin treatment following time : H1 , H2 , H3 , H6 H12 . The population pharmacokin√©tics analysis carry use Monolix , software analysis nonlinear mixed effect model .</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>Inpatient stay intensive care Over 18 year old Presenting MRSA nosocomial pneumonia bacteraemia strain think sensitive Linezolid Simplified Acute Physiological Score ( SAPS ) II &gt; 20 Expected duration life &gt; 7 day . History allergy linezolid antibiotic use Isolation MRSA resistant linezolid Lack seed Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Population pharmacokinetics</keyword>
	<keyword>Linezolid</keyword>
	<keyword>Monolix</keyword>
	<keyword>nonlinear mixed effect model</keyword>
</DOC>